New Class Of Molecules As Histamine-3 Receptor (H3R) Modulators: A New Lead In Clinical Management Of Obesity
Share This:
                           

About The Author

Ajay K Srivastava is a scientist at the Central Drug Research Institute | CDRI, Medicinal and Process Chemistry Division (CDRI) in Lucknow, India.

                       

New Class Of Molecules As Histamine-3 Receptor (H3R) Modulators: A New Lead In Clinical Management Of Obesity

If we don't somehow stem the tide of childhood obesity, we're going to have a huge problem. —Lance Armstrong Comprehensive lifestyle management like diet, physical exercise, and behavior modification are the best ways to treat obesity. An alternative to this is drug-based therapy. Although not preferred or prescribed until lifestyle modifications fall short in achieving that goal, pharmacotherapy provides an opportunity for the obese population to achieve weight loss and to reduce the incidence of associated health hazards like cardiovascular disease,...

Read more